Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid

Thrombosis Research

Volumn 109, Issue 5-6, 2003, Pages 329-332

  Thyzel, E ^a   Siegling, S ^a   Gotting C ^a   Tinneberg, H R ^b   Brinkmann, T ^a   Kleesiek, K ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Fertility; Infertility; Ovarian follicular fluid; Seminal plasma; Tissue factor pathway inhibitor (TFPI)

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; SERINE PROTEINASE INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; AZOOSPERMIA; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; HEALTH STATUS; HUMAN; INFERTILITY; LIQUEFACTION; MALE; NORMAL HUMAN; OLIGOSPERMIA; OOCYTE MATURATION; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; OVULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEMEN ABNORMALITY; SEMEN ANALYSIS; SEMINAL PLASMA; SPERM; SUPEROVULATION; TERATOZOOSPERMIA;

EID: 0038683373     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00210-X     Document Type: Article

References (23)

1. Brinkmann T., Schmidt M., Prohaska W., Kleesiek K. Tissue factor pathway inhibitor (TFPI): biochemistry, genetics and implications for thrombophilia. J. Lab. Med. 25:2001;269-276.
2. Bajaj M.S., Birktoft J.J., Steer S.A., Bajaj S.P. Structure and biology of tissue factor pathway inhibitor. (review) Thromb. Haemost. 86(4):2001;959-972.
3. Rao L.W.M., Rappaport S.I. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood. 69(2):1987;645-651.
4. Osterud B., Bajaj M.S., Bajaj S.P. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. Thromb. Haemost. 73(5):1995;873-875.
5. Brinkmann T., Kaehnert H., Prohaska W., Norfang O., Kleesiek K. Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur. J. Clin. Chem. Clin. Biochem. 32(4):1994;313-317.
6. Lindahl A.K., Sandset P.M., Abilgaard U. The present status of tissue factor pathway inhibitor. Blood Coagul. Fibrinolysis. 3(4):1992;439-449.
7. Hansen J.B., Huseby N.E., Sandset P.M., Svensson B., Lyngmo V., Nordoy A. Tissue factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Arterioscler. Thromb. 14(2):1994;223-229.
8. Sandset P.M., Abilgaard U., Larsen M.L. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb. Res. 50(6):1988;803-813.
9. Driancourt M.-A., Gougeon A., Royère D., Thibault C. Ovarian function. Thibault C., Levasseur M.C., Hunter R.H.F. Reproduction in mammals and man. 1993;281-305 Ellipses, Paris.
10. Greenwald S.G., Terranova P.F. Follicular selection and its control. Knobil E., Neill J.et al. The physiology of reproduction. 1988;387-445 Raven Press, New York.
11. Gentry P.A., Plante L., Schroeder O.B., LaMarre J., Young J.E., Dodds W.G. Human ovarian fluid has functional systems for the generation and modulation of thrombin. Fertil. Steril. 73(4):2000;848-854.
12. Shimada H., Kasakura S., Shiotani M., Nakamura K., Ikeuchi M., Hoshino T. Hypocoagulable state of human preovulatory ovarian follicular fluid: role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid. Biol. Reprod. 64(6):2001;1739-1745.
13. Götting C., Kuhn J., Tinneberg H.-R., Brinkmann T., Kleesiek K. High xylosyltransferase activities in human follicular fluid and cultured granulosa-lutein cells. Mol. Hum. Reprod. 8(12):2002;1079-1086.
14. WHO laboratory manual for the examination of human semen and semen-cervical mucus interactions. 1992;University of Cambridge Press Syndicate, Cambridge.
15. Van Wersch J.W.J., De Vries-Hanje J.C., Ubachs J.M.H. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness. Eur. J. Clin. Chem. Clin. Biochem. 30(8):1992;467-471.
16. Fernandez J.A., Heeb M.J., Radtke K.-P., Griffin J.H. Potent blood coagulant activity of human semen due to proteosome-bound tissue factor. Biol. Reprod. 56(3):1997;757-763.
17. Mann T. The biochemistry of semen and the male reproduction tract. 1964;Wiley, New York.
18. Polak B., Daunter B. Seminal plasma biochemistry: IV. Enzymes involved in the liquefaction of human seminal plasma. Int. J. Androl. 12(3):1989;187-194.
19. Mandal A., Batabyal S.K., Bhattacharyya A.K. Glycerylphosphorylcholine levels in the coagulational groups of human ejaculates. Indian J. Med. Res. 90:1989;186-190.
20. Lilja H., Laurell C.B. Liquefaction of coagulated human semen. Scand. J. Clin. Lab. Invest. 44(5):1984;447-452.
21. Lilja H., Laurell C.B. The predominant protein in human seminal coagulate. Scand. J. Clin. Lab. Invest. 45(7):1985;635-641.
22. Mandal A., Bhattacharyya A.K. Relationship between the coagulation-liquefication property of human ejaculates and their volume, sperm count and motility. Clin. Reprod. Fertil. 5(6):1987;367-371.
23. Falciani M., Gori A.M., Fedi S., Chiarugi L., Simonetti I., Dabizzi R.P. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb. Haemost. 79:1998;495-499.